Avidity Biosciences announces 2021 pipeline updates and research collaboration with MyoKardia
Avidity has entered into a research collaboration with MyoKardia to leverage its genetic cardiomyopathy platform including, among other…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
11 Jan 21
Avidity has entered into a research collaboration with MyoKardia to leverage its genetic cardiomyopathy platform including, among other…
11 Jan 21
FlowTriever is the first thrombectomy system that eliminates the need for cardiopulmonary bypass circuit to treat clot in…
08 Jan 21
ShortCut is the latest addition to Pi-Cardia’s product offering, which includes the Leaflex device – a standalone, non-implant-based…
07 Jan 21
The company is developing a left ventricular assist device, by leveraging its advanced wave membrane pump technology
28 Dec 20
AltaValve is a transcatheter mitral valve replacement (TMVR) device developed by the company
23 Dec 20
The TricValve is a system of two self-expanding biological valves for the treatment of patients with hemodynamically relevant…
22 Dec 20
The trial will assess the safety and efficacy of the investigational Harpoon beating heart mitral valve repair system…
New medical devices approved by the FDA in 2020 include incontinence treatments, diagnostic testing kits and ultrasound systems…
21 Dec 20
Occlutech is one of the leading companies in its field, with several major products including state-of-the-art PFO occluders
21 Dec 20
Collaboration strengthens Peijia's position for competing in untapped market and supports global expansion of HighLife's technology